Mortality within 30 days following systemic anti-cancer therapy, a review of all cases over a 4 year period in a tertiary cancer centre

European Journal of Cancer

Volumn 51, Issue 2, 2015, Pages 233-240

  Khoja, L ^a   McGurk, A ^a   O'Hara, C ^a   Chow, S ^a   Hasan, J ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

30 Day SACT mortality; Clinical governance; NCEPOD; Oncology

Indexed keywords

ARTICLE; CANCER CENTER; CANCER MORTALITY; CANCER THERAPY; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; DECISION MAKING; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC ANTICANCER THERAPY; SYSTEMIC THERAPY; ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; FEMALE; IMMUNOTHERAPY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASMS; OUTCOME ASSESSMENT; PROCEDURES; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SURVIVAL; SURVIVAL RATE; TIME; YOUNG ADULT;

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CAUSE OF DEATH; FEMALE; HUMANS; IMMUNOTHERAPY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84925248442     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.11.011     Document Type: Article

References (15)

1. D.L.M. Mort, N. Smith, K. Protopapa, and M. Mason A review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy. National confidential enquiry into patient outcome and death 2008 Department of Health United Kingdom
2. M.E. O'Brien, A. Borthwick, and A. Rigg Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients Br J Cancer 95 2006 1632 1636
3. Marsden TR. The Royal Marsden integrated governance monitoring report July to September, 2011.
4. J. Yoong, J.A. Seah, and K. Hamilton Mortality within 30 days of receiving systemic anti-cancer therapy at a regional oncology unit: what have we learned? Asia Pac J Clin Oncol 8 2012 325 329
5. S.E. Harrington, and T.J. Smith The role of chemotherapy at the end of life: "when is enough, enough?" JAMA 299 2008 2667 2678
6. C.C. Earle, M.B. Landrum, and J.M. Souza Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26 2008 3860 3866
7. C.C. Earle, B.A. Neville, and M.B. Landrum Trends in the aggressiveness of cancer care near the end of life J Clin Oncol 22 2004 315 321
8. J.R. Murillo Jr., and J. Koeller Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer Oncologist 11 2006 1095 1099
9. E.J. Emanuel, Y. Young-Xu, and N.G. Levinsky Chemotherapy use among medicare beneficiaries at the end of life Ann Intern Med 138 2003 639 643
10. C.C. Earle, B.A. Neville, and M.B. Landrum Evaluating claims-based indicators of the intensity of end-of-life cancer care Int J Qual Health Care 17 2005 505 509
11. J.S. Temel, J.A. Greer, and A. Muzikansky Early palliative care for patients with metastatic non-small-cell lung cancer N Engl J Med 363 2010 733 742
12. B.E. Kiely, M.R. Stockler, and M.H. Tattersall Thinking and talking about life expectancy in incurable cancer Semin Oncol 38 2011 380 385
13. T.J. Smith, and D.L. Longo Talking with patients about dying N Engl J Med 367 2012 1651 1652
14. A.A. Wright, B. Zhang, and N.L. Keating Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study BMJ 348 2014 g1219
15. M. Maltoni, A. Caraceni, and C. Brunelli Prognostic factors in advanced cancer patients: evidence-based clinical recommendations - a study by the steering committee of the European association for palliative care J Clin Oncol 23 2005 6240 6248